GlassScriptPhysician profile
Francis Benz
NPI 1285680397
$7,816.39
in general payments reported to CMS, 2019-2025
55 companies · $1,263 in 2025
The $1,263 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,032 · 2020: $907 · 2021: $756 · 2022: $637 · 2023: $989 · 2024: $1,234 · 2025: $1,263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,485.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $930.39 | 2019-2025 | Cimzia, Rystiggo, Bimzelx |
| Lundbeck LLC | $575.59 | 2021-2025 | Vyepti, Rexulti |
| Supernus Pharmaceuticals, INC. | $528.20 | 2019-2021 | |
| Amgen INC. | $463.72 | 2019-2025 | Tavneos, Otezla, Krystexxa |
| Teva Pharmaceuticals USA, INC. | $387.78 | 2019-2023 | Ajovy |
| Biogen, INC. | $372.40 | 2020-2025 | Leqembi |
| Lilly USA, LLC | $369.20 | 2019-2024 | Amyvid, Kisunla |
| Pfizer INC. | $352.55 | 2024-2025 | |
| Abbvie INC. | $318.73 | 2021-2025 | Qulipta, Ubrelvy |
| Novartis Pharmaceuticals Corporation | $257.18 | 2019-2021 | |
| Acadia Pharmaceuticals INC | $236.76 | 2019-2024 | Nuplazid |
| Mdd US Operations, LLC | $203.08 | 2019-2023 | Gocovri, Apokyn, Myobloc |
| Avanir Pharmaceuticals, INC. | $198.28 | 2019 | |
| Amneal Pharmaceuticals LLC | $195.91 | 2022-2025 | Crexont, Rytary |
| Eisai INC. | $181.76 | 2021-2025 |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francis Benz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.